Skip to content

AptarGroup ATR Inventories

Inventories at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$452.6M+16.4%
Nordson logo
NordsonNDSN
$467.76M-1.3%
Baxter International logo
Baxter InternationalBAX
$2.32B+6.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$14.84M-55.6%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$560.17M+5.0%
AVT
AvantorAVTR

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's inventories?
AptarGroup (ATR) reported inventories of $551.48M in Q1 2026.
How has AptarGroup's inventories changed year-over-year?
AptarGroup's inventories increased by 14.1% year-over-year, from $483.52M to $551.48M.
What is the long-term trend for AptarGroup's inventories?
Over 5 years (2020 to 2025), AptarGroup's inventories has grown at a 7.2% compound annual growth rate (CAGR), from $379.38M to $537.85M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.